Where do Denali Therapeutics Inc.'s ratios come from?

Every ratio is computed from Denali Therapeutics Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Returns
Return on equity	-49.6%-14.4pp	-45.7%-8.3pp	-44.4%-9.4pp	-39.7%-7.1pp	-35.2%-23.9pp
Return on assets	-40%-8.2pp	-40.7%-7.2pp	-39.7%-8.0pp	-35.9%-6.0pp	-31.8%-22.6pp
Return on invested capital	-64.8%-24.5pp	-56.8%-9.5pp	-50.8%-8.2pp	-46.6%-7.6pp	-40.3%-24.1pp
Liquidity
Current ratio	9.3×-0.3×	9.2×+0.7×	9.8×-0.2×	10.3×-2.2×	9.6×-2.2×
Quick ratio	9.3×-0.3×	9.2×+0.7×	9.8×-0.2×	10.3×-2.2×	9.6×-2.2×
Cash ratio	3.5×+2.9×	2.1×+0.4×	1×0.0×	1.6×+0.6×	0.7×-0.1×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$4.96-24.3%	$5.87-21.5%	$5.37-31.0%	$5.99-27.1%	$6.56-32.7%
Valuation
Market capitalization	$3.04B+54.2%	$2.58B-12.1%	$2.12B-49.1%	$2.09B-36.8%	$1.97B-30.9%
Enterprise value	$2.69B+37.1%	$2.41B-14.2%	$2.07B-49.8%	$2B-39.2%	$1.97B-30.9%
Price / book	3.3×+1.5×	2.5×+0.2×	2.3×-0.9×	2×-0.4×	1.8×-0.2×
Free cash flow yield	-13.8%+5.7pp	-16.4%-4.0pp	-19.4%-10.3pp	-17.6%-5.4pp	-19.5%-4.6pp
Earnings yield	-16.7%+6.3pp	-19.9%-5.5pp	-23.5%-13.2pp	-22.9%-10.2pp	-23%-18.2pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Denali Therapeutics Inc.'s ratios come from?: Every ratio is computed from Denali Therapeutics Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.